COHANCE - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

IntraDay Trade Rating: 2.6

📉 Oversold technicals and institutional support offer a bounce setup, but weak momentum and earnings contraction limit conviction.

📈 Positive

• 📉 RSI at 25.2 — deeply oversold, potential for technical rebound.
• 📈 DII holding increased by 9.41% — strong domestic institutional accumulation.
• 💰 Debt-to-equity ratio of 0.04 — minimal leverage risk.
• 📊 ROCE (16.0%) and ROE (12.5%) — decent operational efficiency.

⚠️ Limitation

• 📉 MACD at -38.5 — strong bearish momentum.
• 📉 Volume significantly below average (6.95L vs 26.45L) — weak intraday interest.
• 📉 Trading well below DMA 50 and DMA 200 — confirms breakdown trend.
• 📉 P/E of 80.4 vs industry P/E of 33.1 — extremely overvalued.

📰 Company Negative News

• 📉 PAT dropped from ₹134 Cr. to ₹58.6 Cr. — 22.4% quarterly decline.
• 📉 FII holding reduced by 0.72% — foreign sentiment weakening.

🌟 Company Positive News

• 📈 EPS of ₹12.5 and strong DII support — potential long-term resilience.

🧪 Industry

• 🧬 Operates in life sciences and diagnostics — long-term growth sector with innovation tailwinds.
• 📊 Industry P/E of 33.1 — COHANCE trades at a steep premium.

📌 Conclusion

• 📉 Weak intraday setup with poor momentum and low volume, but oversold RSI may attract tactical buyers.
• 💡 Optimal buy range: ₹735–₹740. Target exit: ₹755–₹765.
• 🛑 Stop-loss: ₹725 to manage downside risk.
• 📤 If already holding, consider exiting near ₹755 if RSI crosses 30 or MACD flattens intraday.

I can also help you identify other life sciences stocks showing stronger volume and RSI recovery setups for intraday trades.